Alternatives to Altasciences

A global leader in clinical pharmacology and bioanalytical sciences.

A global contract research organization specializing in preclinical and translational oncology research.

Developing first-in-class oral therapy for BK polyomavirus infections.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A leading Contract Research Organisation (CRO) specializing in early-phase clinical trials for pharmaceutical and biotechnology companies.

Global life sciences company providing diagnostic and biopharma laboratory services.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops a computational model of the human body for drug discovery and development.

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered spatial biology platform for precision medicine and drug development.

Developing engineered biologics to harness the immune system for disease treatment.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered platform that automates drug discovery through physical AI scientists and robotic experimentation.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-powered cloud quality management system for life sciences.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Biotechnology company focused on developing treatments for rare metabolic diseases.

A biotechnology company developing genetic therapies for rare disorders.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Developing gene editing therapies to lower cholesterol.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered medical imaging analysis and diagnostic support for radiologists.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

Harnessing genetic data for digital insights in rare and germline disorders.